As of January 22, 2025, GoodRx (GDRX) has a market cap of $1.78 billion USD. According to our data, GoodRx is ranked No.4324 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.78 B |
267.10%
|
Dec 31, 2024 | $0.48 B |
-30.60%
|
Dec 29, 2023 | $0.70 B |
43.78%
|
Dec 30, 2022 | $0.49 B |
-85.74%
|
Dec 31, 2021 | $3.41 B |
-18.99%
|
Dec 31, 2020 | $4.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Teladoc Health
TDOC
|
$1.72 B |
83.501 M
|
USA
|
CVS Health
CVS
|
$67.06 B |
0.001 M
|
USA
|
Walgreens Boots Alliance
WBA
|
$9.94 B |
-0.000 M
|
USA
|
Cigna
CI
|
$80.49 B |
-0.002 M
|
USA
|
UnitedHealth
UNH
|
$478.03 B |
-0.009 M
|
USA
|
Humana
HUM
|
$34.20 B |
0.001 M
|
USA
|
McKesson
MCK
|
$74.51 B |
-0.001 M
|
USA
|
Cardinal Health
CAH
|
$31.27 B |
0.001 M
|
USA
|
Hims & Hers Health
HIMS
|
$6.36 B |
0.244 B
|
USA
|
Market Cap | = | GDRX Stock Price | * | GDRX Shares Outstanding |
= | $4.67 | * | 0.10 B | |
= | $1.78 B |